Table 1 Description of studies included in meta-analysis.
Author (year) | Country | Reference Test | Blinded to reference test? | Sample | Sample size (# resistant / # sensitive) | Sensitivity (95% CI) | Specificity (95% CI) |
|---|---|---|---|---|---|---|---|
Ahmad (2002) | Kuwait | BACTEC 460 | Not Specified | Isolate | 29/12 | 0.97 (.82–1.0) | 1.0 (.74–1.0) |
De Oliveira (1998) | Brazil | Proportion | Not Specified | Isolate | 113/15 | 0.97 (.92–.99) | 1.0 (.78–1.0) |
Gamboa (1998) | Spain | BACTEC 460 | Not Specified | Isolate | 46/13 | 1.0 (.92–1.0) | 1.0 (.75–1.0) |
Hirano (1999) | Japan | Proportion | Not Specified | Isolate | 90/26 | 0.92 (.85–.97) | 1.0 (.87–1.0) |
Johansen (2003) | Denmark | BACTEC 460 | Not Specified | Isolate | 35/24 | 0.97 (.85–1.0) | 1.0 (.86–1.0) |
Jureen (2004) | Sweden | BACTEC 460 | Not Specified | Isolate | 27/26 | 1.0 (.87–1.0) | 0.92 (.75–.99) |
Lemus (2004) | Belgium | BACTEC 460, Proportion | Yes | Isolate | 10/10 | 1.0 (.69–1.0) | 1.0 (.69–1.0) |
Rossau (1997) | Belgium | Proportion | Not Specified | Isolate | 203/61 | 0.98 (.95–.1.0) | 1.0 (.94–1.0) |
Sintchenko (1999) | Australia | BACTEC 460 | Not Specified | Isolate | 22/11 | 0.96 (.77–1.0) | 1.0 (.72–1.0) |
Somoskovi (2003) | USA | Proportion | Not Specified | Isolate | 64/37 | 0.95 (.87–.99) | 1.0 (.91–1.0) |
Srivastava (2004) | India | MIC | Not Specified | Isolate | 45/10 | 0.82 (.68–.92) | 1.0 (.69–1.0) |
Tracevska (2002) | Latvia | BACTEC 460 | Not Specified | Isolate | 34/19 | 1.0 (.90–1.0) | 1.0 (.82–1.0) |
Traore (2000) | Belgium | Proportion | Not Specified | Isolate | 266/145 | 0.99 (.96–1.0) | 1.0 (.98–1.0) |
Watterson (1998) | England | BACTEC 460, Proportion | Not Specified | Isolate | 16/16 | 1.0 (.80–1.0) | 0.94 (.70–1.0) |
De Beenhouwer (1995) | Belgium | Proportion | Not Specified | Clinical Specimen | 21/46 | 0.91 (.70–1.0) | 1.0 (.92–1.0) |
Gamboa (1998) | Spain | BACTEC 460 | Not Specified | Clinical Specimen | 46/13 | 0.98 (.89–1.0) | 1.0 (.75–1.0) |
Johansen (2003) | Denmark | BACTEC 460 | Not Specified | Clinical Specimen | 26/21 | 1.0 (.87–1.0) | 1.0 (.84–1.0) |
Watterson (1998) | England | BACTEC 460, proportion | Yes | Clinical Specimen | 10/24 | 0.80 (.44–.98) | 1.0 (.86–1.0) |